Zhejiang Huahai Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, manufacture and sales of generic drugs, biological drugs, innovative drugs and specialty active pharmaceutical ingredients (APIs) in multiple dosage forms. The Company's pharmaceutical preparations and APIs cover cardiovascular, mental disorder, nervous system and anti-infection fields. The Company's products include irbesartan hydrochlorothiazide tablets, losartan potassium tablets, paroxetine hydrochloride tablets, sertraline hydrochloride tablets, oseltamivir phosphate capsules, linagliptin tablets, dabigatran etexilate capsules, pemetrexed disodium for injection, esomeprazole magnesium enteric-coated capsules, febuxostat tablets and torsemide injection. The Company also provides technical services and pharmaceutical import and export trade business.